227 related articles for article (PubMed ID: 28807210)
1. Personalized treatment in patients with colorectal liver metastases.
Moris D; Pawlik TM
J Surg Res; 2017 Aug; 216():26-29. PubMed ID: 28807210
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
3. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
[TBL] [Abstract][Full Text] [Related]
4. Colorectal Liver Metastases: Does the Future of Precision Medicine Lie in Genetic Testing?
Barbon C; Margonis GA; Andreatos N; Rezaee N; Sasaki K; Buettner S; Damaskos C; Pawlik TM; He J; Wolfgang CL; Weiss MJ
J Gastrointest Surg; 2018 Jul; 22(7):1286-1296. PubMed ID: 29644557
[TBL] [Abstract][Full Text] [Related]
5. Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic Colorectal Cancer.
Diehl TM; Abbott DE
Curr Treat Options Oncol; 2021 Jul; 22(9):82. PubMed ID: 34224023
[TBL] [Abstract][Full Text] [Related]
6. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
[TBL] [Abstract][Full Text] [Related]
7. [Hepatic metastasis of colorectal cancer--current therapeutic possibilities].
Popescu I; Alexandrescu S
Chirurgia (Bucur); 2010; 105(2):155-69. PubMed ID: 20540227
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases.
Pikoulis E; Margonis GA; Andreatos N; Sasaki K; Angelou A; Polychronidis G; Pikouli A; Riza E; Pawlik TM; Antoniou E
Anticancer Res; 2016 Sep; 36(9):4805-11. PubMed ID: 27630332
[TBL] [Abstract][Full Text] [Related]
9. Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making.
Jones RP; Brudvik KW; Franklin JM; Poston GJ
Eur J Surg Oncol; 2017 May; 43(5):875-883. PubMed ID: 28302330
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
[TBL] [Abstract][Full Text] [Related]
11. Survival and Prognostic Factors of Colorectal Liver Metastases After Surgical and Nonsurgical Treatment.
Lemke J; Cammerer G; Ganser J; Scheele J; Xu P; Sander S; Henne-Bruns D; Kornmann M
Clin Colorectal Cancer; 2016 Dec; 15(4):e183-e192. PubMed ID: 27269232
[TBL] [Abstract][Full Text] [Related]
12. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
[TBL] [Abstract][Full Text] [Related]
13. Extending the frontiers of resectability in advanced colorectal cancer.
Chun YS; Vauthey JN
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S52-8. PubMed ID: 18006265
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary treatment of colorectal liver metastases.
Schiergens TS; von Einem J; Thomas MN; Albertsmeier M; Giessen-Jung C; Dörsch M; Heiliger C; Drefs M; Andrassy J; Modest DP; Stintzing S; Guba M; Angele M; Werner J; Rentsch M
Minerva Med; 2017 Dec; 108(6):527-546. PubMed ID: 28889727
[TBL] [Abstract][Full Text] [Related]
15. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
[TBL] [Abstract][Full Text] [Related]
16. Management of patients with colorectal liver metastasis in eleven questions and answers.
Andres A; Majno P; Terraz S; Morel P; Roth A; Rubbia-Brandt L; Schiffer E; Ris F; Toso C
Expert Rev Anticancer Ther; 2016 Dec; 16(12):1277-1290. PubMed ID: 27744725
[TBL] [Abstract][Full Text] [Related]
17. Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study.
Viganò L; Russolillo N; Ferrero A; De Rosa G; Ferreri E; Forchino F; Sperti E; Capussotti L
Ann Surg; 2014 Nov; 260(5):878-84; discussion 884-5. PubMed ID: 25379857
[TBL] [Abstract][Full Text] [Related]
18. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
[TBL] [Abstract][Full Text] [Related]
19. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
